anti-AMAC1 antibody product blog
Tags: Antibody; Polyclonal Antibody; AMAC1; anti-AMAC1 antibody;
The AMAC1 slc35g3 (Catalog #MBS856130) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The AMAC1 Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s AMAC1 can be used in a range of immunoassay formats including, but not limited to, Peptide ELISA (EIA), Western Blot (WB).Peptide ELISA: 1:5,000-1:10,000
WB: 1:500-1:1,000. Researchers should empirically determine the suitability of the AMAC1 slc35g3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The AMAC1 slc35g3 product has the following accession number(s) (GI #119600567) (NCBI Accession #EAW80161.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the AMAC1 Antibody with the following immunoassay(s):
Testing Data
Rabbit polyclonal AMAC1 (1) antibody was raised against a peptide from N terminal residues of human AMAC1 protein.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing AMAC1 are readily searchable from our website. Different antibodies against the same target such as AMAC1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.